1. Introduction
Netherton syndrome is an uncommon autosomal recessive disorder characterized by congenital ichthyosis with defective cornification, bamboo hair, and severe atopic manifestation. It is caused by mutations in
In 1958, Netherton described the bamboo-like deformity in the fragile hairs in a girl with erythematous scaly dermatitis.[2] In 1985, Greene and Muller emphasized the triad of Netherton syndrome: ichthyosis, atopy, and trichorrhexis invaginata.[3] In 2000, Chavanas
In this session, we summarize (1) the clinical features of Netherton syndrome, (2) the genetic relationship of
2. The clinical features of Netherton syndrome
Netherton syndrome is an uncommon autosomal recessive disease characterized by ichthyosis linearis circumflexa and/or congenital ichthyosiform erythroderma, hair shaft defects including trichorrhexis invaginata, trichorrhexis nodosa and pili torti and atopic manifestations with an elevated IgE level, frequent asthma and food allergies.[1] It is caused by mutations in
The infants with Netherton syndrome commonly show a generalized erythroderma covered by fine, translucent scales, which can be difficult to distinguish clinically from erythrodermic psoriasis, non-bullous congenital ichthyosiform erythroderma, or other infantile erythrodermas.[7] Electron microscopy is useful for diagnosis. It illustrates premature lamellar body secretions and foci of electron-dense materials in the intercellular spaces of stratum corneum.[7] Patients with a mild phenotype of ichthyosis linearis circumflexa on the palms and soles will have mutations located downstream near the C-terminal end, while a severe erythrodermic phenotype will be associated with nucleotide changes with early truncations in
Trichorrhexis invaginata (bamboo hair) is a focal defect of the hair shaft that produces development of torsion nodules and invaginated nodules.[1] Invagination of affected hairs is caused by softness of the cortex in the keratogenous zone because of an incomplete formation of disulfide bonds.[10]
Lack of LEKTI causes stratum corneum detachment secondary to epidermal proteases hyperactivity.[11] This skin barrier defect favors allergen absorption and is generally regarded as the underlying cause for atopic dermatitis-like lesions in Netherton syndrome.[11] Uncontrolled kallikreins (KLK)s activity in Netherton syndrome epidermis can trigger atopic dermatitis-like lesions, independently of the environment and the adaptive immune system.[11]
3. The genetic relationship of SPINK5 to atopic dermatitis
Atopic dermatitis is a chronic and relapsing inflammatory skin disorder caused by multiple genetic and environmental factors. A recent genome-wide association studies for atopic dermatitis identified susceptibility loci at 1q21.3 (
Association of
Fortugno
4. The molecular functions
The epidermis consists of the basal layer, the spinous layer, the granular layer and the cornified layer. The hair follicle is constructed by the inner root sheath, the outer root sheath and the hair bulb. LEKTI is expressed in the granular layer of the epidermis and in the inner root sheet of hair follicle and acts as an inhibitor of multiple serine proteases.4 LEPTI contains fifteen serine protease inhibitor domains and its proteolytic fragments inhibit epidermal proteases.22-28 LEPTI can inhibit the epidermal serine protease KLK5, KLK6, KLK7, KLK13 and KLK14.29 LEKTI-domain 6 was shown to specifically inhibit KLK5 and KLK7 in the mid-to-high nanomolar range.[30] Thus, protease inhibitors such as LEPTI are crucial players for controlling protease activity.
KLK5 can cleave desmoglein 1, inducing the detachment of stratum corneum and subsequent severe skin barrier defect which is associated with high permeability of various allergens. Unrepressed KLK5 activity can be present in loss-of-functional mutation in
KLK7 is involved in stratum corneum desquamation via the disruption of corneodesmosomes and the cell-cell adhesion junctions of corneocytes by hydrolyzing the two mayor cadherins (corneodesmosin and desmocollin 1) in the extracellular region of the junctions.[32]
Matriptase is a transmembrane tripsin-like serine protease having the capacity of autoactivation and subsequent occurrence of proteolytic cascade reactions.[33, 34] Sales
The functional loss or insufficiency of LEKTI induces relative excess activation of serine protease toward severe skin allergy.
5. Conclusion
Recently, studies for the interaction between proteases and protease inhibitors are focused on the elucidation of pathogenesis of Netherton syndrome, atopic dermatitis, asthma, and food allergies. Atopic manifestation with an elevated IgE level in Netherton syndrome prompted researches to investigate the genetic relationship between atopic dermatitis and genetic polymorphisms. LEKTI encoded by functionally decreased polymorphisms can alter proteolytic activation and protease deregulation. The relationship between atopic dermatitis and improper cornification has been focused not only in model mice of Netherton syndrome but also in flaky tail mice with double filaggrin and loricrin deficiencies.[35] Further study will discover more precise mechanism in cornification, which would provide novel strategies for effective treatment for Netherton syndrome and atopic dermatitis.
References
- 1.
Netherton syndrome: successful use of topical tacrolimus and pimecrolimus in four siblings. Int J DermatolSun J. D Linden K. G 2006 45 693 7 - 2.
Netherton E. W A unique cse of trichorrhexis nodosa; bamboo hairs. AMA Arch Derm1958 78 483 7 - 3.
Netherton’s syndrome. Report of a case and review ofGreene S. L Muller S. A the literature. J Am Acad Dermatol 1985 13 329 37 - 4.
Chavanas S Bodemer C Rochat A et al Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet2000 25 141 2 - 5.
Descargues P Deraison C Bonnart C et al Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet2005 37 56 65 - 6.
Sales K. U Masedunskas A Bey A. L et al Matriptase initiates activation of epidermal pro-kallikrein and disease onset in a mouse model of Netherton syndrome Nat Genet2010 42 676 83 - 7.
Fartasch M Williams M. L Elias P. M et al Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol1999 135 823 32 - 8.
DiGiovanna JJ et al. The spectrum of pathogenic mutations in SPINK5 in 19 families with Netherton syndrome: implications for mutation detection and first case of prenatal diagnosis. J Invest DermatolSprecher E Chavanas S 2001 117 179 87 - 9.
Mizuno Y Suga Y Muramatsu S et al A Japanese infant with localized ichthyosis linearis circumflexa on the palms and soles harbouring a compound heterozygous mutation in the SPINK5 gene Br J Dermatol2005 153 661 3 - 10.
Ito M Ito K Hashimoto K Pathogenesis in trichorrhexis invaginata (bamboo hair). J Invest Dermatol1984 83 1 6 - 11.
Briot A Deraison C Lacroix M et al Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome J Exp Med2009 206 1135 47 - 12.
Sun L. D Xiao F. L Li Y et al Genome-wide association study identifies two new susceptibility loci for atopic dermatitis in the Chinese Han population. Nat Genet2011 43 690 4 - 13.
Paternoster L Standl M Chen C. M et al Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis. Nat Genet2011 44 187 92 - 14.
Andiappan A. K Foo J. N Choy M. W et al Validation of GWAS loci for atopic dermatitis in a Singapore Chinese population. J Invest Dermatol2012 132 1505 7 - 15.
Jin Y Birlea S. A Fain P. R et al Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet2012 44 676 80 - 16.
Petukhova L Duvic M Hordinsky M et al Genome-wide association study in alopecia areata implicates both innate and adaptive immunity 2010 466 113 7 - 17.
Walley A. J Chavanas S Moffatt M. F et al Gene polymorphism in Netherton and common atopic disease. Nat Genet2001 29 175 8 - 18.
Kato A Fukai K Oiso N et al Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population Br J Dermatol2003 148 665 9 - 19.
Lan C. C Tu H. P Wu C. S et al Distinct SPINK5 and IL-31 polymorphisms are associated with atopic eczema and non-atopic hand dermatitis in Taiwanese nursing population. Exp Dermatol2011 20 975 9 - 20.
Zhao L. P Di Z Zhang L et al Association of SPINK5 gene polymorphisms with atopic dermatitis in Northeast China. J Eur Acad Dermatol Venereol2012 26 572 7 - 21.
Fortugno P Furio L Teson M et al The 420K LEKTI variant alters LEKTI proteolytic activation and results in protease deregulation: implications for atopic dermatitis. Hum Mol Genet, in press. - 22.
LEKTI proteolytic processing in human primary keratinocytes, tissue distribution and defective expression in Netherton syndrome. Hum Mol GenetBitoun E Micheloni A Lamant L et al 2003 12 2417 30 - 23.
hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J DermatolEgelrud T Brattsand M Kreutzmann P et al 2005 153 1200 3 - 24.
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol ChemBorgono C. A Michael I. P Komatsu N et al 2007 282 3640 52 - 25.
LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol CellDeraison C Bonnart C Lopez F et al 2007 18 3607 19 - 26.
Ovaere P Lippens S Vandenabeele P et al The emerging roles of serine protease cascades in the epidermis Trends Biochem Sci2009 34 453 63 - 27.
Proteolytic activation cascade of the Netherton Syndrome-Defective Protein, LEKTI, in the epidermis: implications for skin homeostasis. J Invest DermatolFortugno P Bresciani A Paolini C et al 2011 131 2223 32 - 28.
Lacroix M Lacaze-buzy L Furio L et al Clinical expression and new SPINK5 splicing defects in Netherton syndrome: unmasking a frequent founder synonymous mutation and unconventional intronic mutations. J Invest Dermatol2012 132 575 82 - 29.
A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol ChemBorgono C. A Michael I. P Komatsu N et al 2007 282 3640 52 - 30.
hK5 and hK7, two serine proteinases abundant in human skin, are inhibited by LEKTI domain 6. Br J DermatolEgelrud T Brattsand M Kreutzmann P et al 2005 153 1200 3 - 31.
Furio L Hovnanian A When activity requires breaking up: LEKTI proteolytic activation cascade for specific proteinase inhibition. J Invest Dermatol2011 131 2169 73 - 32.
Fernández I. S Ständker L Mägert H. J et al Crystal structure of human epidermal kallikrein 7 (hK7) synthesized directly in its native state in E. coli: insights into the atomic basis of its inhibition by LEKTI domain 6 (LD6) J Mol Biol2008 377 1488 97 - 33.
Takeuchi T Harris J. L Huang W et al Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem2000 275 26333 42 - 34.
Lee S. L Dickson R. B Lin C. Y Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem2000 275 36720 5 - 35.
Nakai K Yoneda K Hosokawa Y et al Reduced expression of epidermal growth factor receptor, e-cadherin, and occludin in the skin of flaky tail mice is due to filaggrin and loricrin deficiencies. Am J Pathol2012 181 969 77